Search for other papers by Rudolf Hoermann in
Google Scholar
PubMed
Search for other papers by John E.M. Midgley in
Google Scholar
PubMed
Search for other papers by Rolf Larisch in
Google Scholar
PubMed
Ruhr Center for Rare Diseases (CeSER), Ruhr University of Bochum and Witten/Herdecke University, Bochum, Germany
Search for other papers by Johannes W. Dietrich in
Google Scholar
PubMed
3 ) and FT 4 , which also maintain interdependent equilibrium positions. While allowing for greater flexibility in the physiological responses of individuals across the euthyroid reference range, this may demand significant variation in the
Search for other papers by Linda M. Thienpont in
Google Scholar
PubMed
Search for other papers by Katleen Van Uytfanghe in
Google Scholar
PubMed
Search for other papers by Sofie Van Houcke in
Google Scholar
PubMed
Search for other papers by Barnali Das in
Google Scholar
PubMed
Search for other papers by James D. Faix in
Google Scholar
PubMed
Search for other papers by Finlay MacKenzie in
Google Scholar
PubMed
Search for other papers by Frank A. Quinn in
Google Scholar
PubMed
Search for other papers by Michael Rottmann in
Google Scholar
PubMed
Search for other papers by Annick Van den Bruel in
Google Scholar
PubMed
<9 pmol/l). This reconfirmed that, currently, FT4 measurement results outside the range of one assay are well within that of another, which can confuse clinicians when they do not consider assay-specific reference intervals. For TSH, concentration
Search for other papers by John Lazarus in
Google Scholar
PubMed
Search for other papers by Rosalind S. Brown in
Google Scholar
PubMed
Search for other papers by Chantal Daumerie in
Google Scholar
PubMed
Search for other papers by Alicja Hubalewska-Dydejczyk in
Google Scholar
PubMed
Search for other papers by Roberto Negro in
Google Scholar
PubMed
Search for other papers by Bijay Vaidya in
Google Scholar
PubMed
Introduction Subclinical hypothyroidism (SCH) in pregnancy is defined by a serum thyroid-stimulating hormone (TSH) concentration higher than the upper limit of the pregnancy-related reference range associated with a normal serum thyroxine [T 4
DZHK (German Center for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany
Search for other papers by Till Ittermann in
Google Scholar
PubMed
Search for other papers by Roberto Lorbeer in
Google Scholar
PubMed
Search for other papers by Daniel Tiller in
Google Scholar
PubMed
Search for other papers by Ina Lehmphul in
Google Scholar
PubMed
Search for other papers by Alexander Kluttig in
Google Scholar
PubMed
DZHK (German Center for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany
Search for other papers by Stephan B. Felix in
Google Scholar
PubMed
Search for other papers by Karl Werdan in
Google Scholar
PubMed
Search for other papers by Karin Halina Greiser in
Google Scholar
PubMed
Search for other papers by Josef Köhrle in
Google Scholar
PubMed
DZHK (German Center for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany
Search for other papers by Henry Völzke in
Google Scholar
PubMed
DZHK (German Center for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany
Search for other papers by Marcus Dörr in
Google Scholar
PubMed
1 ). In all three studies individuals with a TSH <0.3 mIU/l were in the median older than individuals with a TSH in the reference range. This difference was more pronounced in the SHIP studies than in CARLA. In the SHIP studies, individuals with a
Departments of Vascular Medicine, University of Amsterdam, Amsterdam
Search for other papers by Laura P.B. Elbers in
Google Scholar
PubMed
Search for other papers by Hjalmar A. Boon in
Google Scholar
PubMed
Search for other papers by Maaike I. Moes in
Google Scholar
PubMed
Departments of Vascular Medicine, University of Amsterdam, Amsterdam
Search for other papers by Bregje van Zaane in
Google Scholar
PubMed
Departments of Vascular Medicine, University of Amsterdam, Amsterdam
Search for other papers by Dees P.M. Brandjes in
Google Scholar
PubMed
Search for other papers by Eric Fliers in
Google Scholar
PubMed
Search for other papers by Harry R. Büller in
Google Scholar
PubMed
Einthoven Laboratory for Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by Suzanne Cannegieter in
Google Scholar
PubMed
Departments of Vascular Medicine, University of Amsterdam, Amsterdam
Search for other papers by Victor E.A. Gerdes in
Google Scholar
PubMed
reference range had an increased risk of major bleeding compared to those with higher FT 4 levels, suggesting that FT 4 levels play a role in the etiology of major bleeding in VKA users. Bleeding is one of the major short-term complications after
Search for other papers by Shinsuke Shinkai in
Google Scholar
PubMed
Medical Education Center, Hamamatsu University School of Medicine, Shizuoka, Japan
Search for other papers by Kenji Ohba in
Google Scholar
PubMed
Search for other papers by Kennichi Kakudo in
Google Scholar
PubMed
Search for other papers by Takayuki Iwaki in
Google Scholar
PubMed
Search for other papers by Yoshihiro Mimura in
Google Scholar
PubMed
Search for other papers by Akio Matsushita in
Google Scholar
PubMed
Search for other papers by Go Kuroda in
Google Scholar
PubMed
Search for other papers by Yuki Sakai in
Google Scholar
PubMed
Search for other papers by Nobuhiko Nishino in
Google Scholar
PubMed
Department of Pharmacology, Hamamatsu University School of Medicine, Shizuoka, Japan
Search for other papers by Kazuo Umemura in
Google Scholar
PubMed
Search for other papers by Takafumi Suda in
Google Scholar
PubMed
Search for other papers by Shigekazu Sasaki in
Google Scholar
PubMed
of 0.01 mIU/L (reference range: 0.05–5.00), a free thyroxine level of 23.2 pmol/L (reference range: 11.6–21.9), and a free tri-iodothyronine level of 6.6 pmol/L (reference range: 3.5–6.2) as measured by ECLusys (Roche Diagnostics K.K., Tokyo, Japan
Search for other papers by Thea Riis in
Google Scholar
PubMed
Search for other papers by Steen Joop Bonnema in
Google Scholar
PubMed
Search for other papers by Thomas Heiberg Brix in
Google Scholar
PubMed
Search for other papers by Lars Folkestad in
Google Scholar
PubMed
.8 2.9 2.1 >3 3.2 1.9 2.8 2.1 2.4 1.5 CCI, Charlson Comorbidity Index; HT, hyperthyroid; HTP, hyperthyroid population; IQR, interquartile range; n , total number of events; RP, reference population. Risk of
Search for other papers by Tina Toft Kristensen in
Google Scholar
PubMed
Search for other papers by Jacob Larsen in
Google Scholar
PubMed
Search for other papers by Palle Lyngsie Pedersen in
Google Scholar
PubMed
Search for other papers by Anne-Dorthe Feldthusen in
Google Scholar
PubMed
Search for other papers by Christina Ellervik in
Google Scholar
PubMed
Search for other papers by Søren Jelstrup in
Google Scholar
PubMed
Search for other papers by Jan Kvetny in
Google Scholar
PubMed
Introduction Whereas hemithyroidectomy is associated with a recognized risk of overt hypothyroidism [ 1 ], the significance of perturbations of thyroid-stimulating hormone (TSH) and thyroid hormones within the laboratory reference ranges after
Search for other papers by Joke Marlier in
Google Scholar
PubMed
Department of Internal Medicine & Pediatrics, Ghent University, Ghent, Belgium
Search for other papers by Guy T’Sjoen in
Google Scholar
PubMed
Department of Internal Medicine & Pediatrics, Ghent University, Ghent, Belgium
Search for other papers by Jean Kaufman in
Google Scholar
PubMed
Department of Internal Medicine & Pediatrics, Ghent University, Ghent, Belgium
Search for other papers by Bruno Lapauw in
Google Scholar
PubMed
/kg body weight, aiming for free thyroxine serum levels (fT4) prior to intake in the upper part of normal reference ranges ( 1 ). However, variability in TH absorption and metabolism, concomitant treatments and inaccurate interpretation of TSH levels still
Department of Endocrinology, Universidade Federal do Rio de Janeiro – UFRJ, Faculdade de Medicina, Rio de Janeiro, RJ, Brazil
Search for other papers by Marise Codeco de Andrade Barreto in
Google Scholar
PubMed
Search for other papers by Natalia Treistman in
Google Scholar
PubMed
Search for other papers by Lara Bessa Campelo Pinheiro Cavalcante in
Google Scholar
PubMed
Search for other papers by Daniel Bulzico in
Google Scholar
PubMed
Search for other papers by Fernanda Accioly de Andrade in
Google Scholar
PubMed
Search for other papers by Rossana Corbo in
Google Scholar
PubMed
Department of Endocrinology, Universidade Federal do Rio de Janeiro – UFRJ, Faculdade de Medicina, Rio de Janeiro, RJ, Brazil
Search for other papers by Paulo Alonso Garcia Alves Junior in
Google Scholar
PubMed
Department of Endocrinology, Universidade Federal do Rio de Janeiro – UFRJ, Faculdade de Medicina, Rio de Janeiro, RJ, Brazil
Search for other papers by Fernanda Vaisman in
Google Scholar
PubMed
.01–7.81) AMH out-of-reference range for age 10 (21) N/A Age at AMH measurement 47 (100) 26.1 ± 9.2 25 (12.4–50.8) Interval (years) between last RAI and AMH measurement 47 (100) 10.7 ± 7.2 10.5 (0.7–26.2) Pregnancies ( n = 17